Alteplase for Stroke With Unknown Onset Time in Chronic Kidney Disease: A Pooled Analysis of Individual Participant Data

Although chronic kidney disease (CKD) is associated with worse stroke outcomes, data regarding the influence of CKD on intravenous thrombolysis outcomes are scarce. We sought to assess the efficacy and safety of intravenous thrombolysis for acute ischemic stroke with unknown onset time in patients w...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Stroke (1970) 2022-11, Vol.53 (11), p.3295-3303
Hauptverfasser:	Miwa, Kaori, Koga, Masatoshi, Jensen, Märit, Inoue, Manabu, Yoshimura, Sohei, Fukuda-Doi, Mayumi, Boutitie, Florent, Ma, Henry, Ringleb, Peter A., Wu, Ona, Schwamm, Lee H., Warach, Steven, Hacke, Werner, Davis, Stephen M., Donnan, Geoffrey A., Gerloff, Christian, Thomalla, Götz, Toyoda, Kazunori
Format:	Artikel
Sprache:	eng
Schlagworte:	Brain Ischemia - drug therapy Fibrinolytic Agents - therapeutic use Humans Intracranial Hemorrhages - drug therapy Ischemic Stroke Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - drug therapy Statistics Stroke - drug therapy Thrombolytic Therapy Tissue Plasminogen Activator - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!